What is Cervical Cancer Screening?
Cervical cancer screening is a vital preventive health process used to identify pre-cancerous cell changes or high-risk viral infections before cervical cancer has a chance to develop. This proactive approach allows medical providers to detect anomalies in the cervix—the lower part of the uterus that connects to the vagina—at a highly treatable stage. By scheduling regular screenings, women can significantly reduce their risk of developing cervical cancer.
At Miami Women’s Center, our comprehensive cervical cancer screening program utilizes highly sensitive diagnostic laboratory testing, advanced tracking protocols, and patient-centered care to protect your long-term reproductive health.
Request an AppointmentFrequently Asked Questions About Cervical Cancer Screening
Is cervical cancer screening different from a routine pelvic exam?
Yes. A routine pelvic exam is a physical evaluation where your gynecologist manually checks your reproductive organs (uterus, ovaries, and vaginal walls) for lumps, pain, or structural irregularities. Cervical cancer screening, however, requires collecting a microscopic sample of cells or fluid directly from the cervix using a soft brush or spatula to test for cellular mutations or viral DNA in a laboratory setting.
How often should I undergo cervical cancer screening?
Miami Women’s Center follows the clinical guidelines established by leading national health organizations:
- Ages 21 to 29: Screening is recommended every 3 years using a conventional or liquid-based Pap smear to look for abnormal cell changes.
- Ages 30 to 65: Screening shifts to a high-risk HPV test alone every 5 years, a co-test combining both a Pap smear and an HPV test every 5 years, or a standard Pap smear alone every 3 years.
- Ages 65 and Older: Screenings can typically be discontinued if you have a consistent history of normal results over the prior 10 years and no history of high-grade precancerous lesions.
Can I still be screened if I am currently on my period?
While mild spotting or very light bleeding will not interfere with modern liquid-based laboratory tests, it is generally ideal to schedule your screening appointment for a time when you are not actively menstruating. Heavy menstrual flow can occasionally obscure the sample, making it difficult for the laboratory pathologist to read the cervical cells accurately.
What are the main risk factors for developing cervical cancer?
The primary risk factor for cervical cancer is persistent infection with high-risk strains of the Human Papillomavirus (HPV). Other factors that can increase your risk include a compromised immune system, smoking, long-term use of oral contraceptives, or missing your regular routine gynecological screening appointments.
Our Screening Methods & Care Pathways
When you establish your preventive care with Miami Women’s Center, we determine the optimal screening method based on your age, lifestyle, and individual medical history:
- Liquid-Based Cytology (Pap Smear): Collecting cells from the outer surface and canal of the cervix to evaluate them for squamous cell abnormalities or glandular changes.
- High-Risk HPV Testing: Analyzing the sample at a molecular level to detect the presence of HPV strains 16, 18, and other high-risk variations known to cause cellular changes.
- Abnormal Result Follow-Up: If your screening indicates atypical or dysplastic cells, our clinic provides immediate access to diagnostic colposcopies, biopsies, and advanced management protocols to treat precancerous tissue efficiently.